SS-31 (Elamipretide): The Mitochondria-Targeted Peptide Reversing Cellular Aging
SS-31: Reaching the Root of Cellular Aging
Every hallmark of aging — reduced energy, muscle wasting, cognitive decline, skin deterioration, cardiovascular dysfunction — traces back, at least in part, to the same source: mitochondrial dysfunction. Mitochondria are not merely power plants; they are the hub of cellular life, death, and signaling. When they fail, cells fail.
SS-31, also known as Elamipretide or MTP-131, represents a novel approach to this fundamental problem. Rather than targeting aging downstream — at symptoms and pathological endpoints — SS-31 targets the mitochondrial inner membrane directly, addressing the structural and functional decline that underlies aging at the cellular level.
What Makes SS-31 Unique: Cardiolipin Targeting
Most antioxidant compounds distribute freely throughout the body and have limited ability to reach the intracellular compartments where oxidative damage is most severe. SS-31 is different. Its design incorporates alternating aromatic and basic amino acid residues that give it an amphipathic character, allowing it to penetrate lipid membranes with unusual efficiency. It accumulates preferentially in the inner mitochondrial membrane (IMM) — reaching concentrations there that are orders of magnitude higher than in the surrounding cytoplasm.
Once at the IMM, SS-31 binds specifically to cardiolipin — a unique phospholipid found almost exclusively in the inner mitochondrial membrane. Cardiolipin is not just a structural molecule; it is a critical functional platform. It cradles cytochrome c within the electron transport chain complexes, facilitating efficient electron transfer. It stabilizes the cristae architecture that provides the surface area for ATP synthesis. It anchors the ATP synthase complexes that produce cellular energy.
Szeto (2006), introducing SS-31 in the AAPS Journal, described how cardiolipin oxidation is one of the earliest and most damaging events in mitochondrial dysfunction. Oxidized cardiolipin releases cytochrome c from the inner membrane — triggering apoptotic cascades and disrupting electron transport chain function simultaneously. By protecting cardiolipin from oxidation, SS-31 addresses this initiating event directly.
What Happens to Mitochondria With Age
The relationship between aging and mitochondrial decline is bidirectional:
- Oxidative stress accumulates from years of electron transport chain activity, progressively damaging mitochondrial DNA, proteins, and lipids
- Mitochondrial membrane potential (ΔΨm) — the electrochemical gradient that drives ATP synthesis — declines, reducing energy output
- Cristae remodeling leads to inefficient ATP synthase configuration
- Mitofusin and dynamin-related proteins governing mitochondrial fusion/fission balance are disrupted
- Mitophagy (clearance of damaged mitochondria) becomes impaired, allowing dysfunctional units to accumulate
Each of these processes compounds the others, creating a downward spiral of declining cellular function with age.
Restoring Mitochondrial Membrane Potential in Aged Muscle
Siegel et al. (2013) published research in PLoS ONE demonstrating one of the most direct demonstrations of SS-31's anti-aging effects: administration to aged mice restored mitochondrial membrane potential and ATP production in skeletal muscle to levels comparable to young animals. The treated aged mice also showed measurable improvements in muscle fiber contraction and force generation.
This finding is profoundly significant. It demonstrates not just that SS-31 can slow mitochondrial decline, but that it can reverse existing dysfunction — even in tissue that has already undergone substantial age-related changes.
Cardiac and Renal Protection
SS-31's cardioprotective effects have been the most extensively studied in preclinical models. Chatfield et al. (2019) in ESC Heart Failure demonstrated that SS-31 improved mitochondrial cristae architecture, preserved cytochrome c retention, and restored ATP production in heart failure models. Treated animals showed improved cardiac output and exercise capacity.
The renal protective effects are equally compelling. Zhao et al. (2019) in Free Radical Biology and Medicine showed SS-31 significantly attenuated acute kidney injury by preserving mitochondrial morphology, reducing ROS production, and preventing the tubular cell apoptosis that drives kidney damage.
SS-31 and Visible Aging
The connection between mitochondrial health and visible aging is increasingly recognized. Skin fibroblasts and keratinocytes are among the most metabolically active cells in the body, requiring constant ATP for collagen synthesis, barrier maintenance, and UV damage repair. As mitochondrial function declines, these energy-intensive processes slow, manifesting as:
- Reduced collagen synthesis and skin thinning
- Impaired DNA repair after UV exposure, accelerating photoaging
- Decreased cellular turnover, leading to dull, less resilient skin
- Reduced production of hyaluronic acid and glycosaminoglycans
By restoring mitochondrial membrane potential and ATP production at the cellular level, SS-31 research is exploring whether the energetic substrate for skin regeneration can be directly restored.
Frequently Asked Questions
What is SS-31?
SS-31 (Elamipretide or MTP-131) is a cell-permeable, mitochondria-targeted tetrapeptide that binds cardiolipin on the inner mitochondrial membrane, protecting it from oxidation and restoring mitochondrial architecture, membrane potential, and ATP production.
How does SS-31 target mitochondria?
SS-31 has an amphipathic structure with alternating aromatic and basic residues that allows it to penetrate lipid membranes and accumulate in the inner mitochondrial membrane at concentrations far exceeding those in the surrounding cytoplasm. Its cardiolipin-binding specificity directs it precisely where mitochondrial dysfunction originates.
What is cardiolipin and why does it matter?
Cardiolipin is a phospholipid almost exclusively found in the inner mitochondrial membrane. It cradles cytochrome c in the electron transport chain, stabilizes cristae architecture, and anchors ATP synthase complexes. When cardiolipin is oxidized (as happens with aging), these functions fail and mitochondrial energy production collapses.
What is the sequence and molecular weight of SS-31?
SS-31 has the sequence D-Arg-Dmt-Lys-Phe-NH2, a molecular weight of approximately 638.79 g/mol, and a CAS number of 736992-21-5. It is supplied as a lyophilized powder.
Disclaimer: All products mentioned are strictly for research purposes only. Not for human consumption.